The Claim
A 12-week low-carbohydrate energy-restricted diet in adults with type 2 diabetes and obesity reduces circulating fibroblast growth factor 21 (FGF21) by -161.2 pg/mL (p=0.035), suggesting normalization of hepatokine secretion patterns associated with improved metabolic health.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When people with type 2 diabetes and obesity follow a low-carb diet for 12 weeks, it lowers a specific protein in their blood that's linked to better health.
See the scientific wording
A 12-week low-carbohydrate energy-restricted diet in adults with type 2 diabetes and obesity reduces circulating fibroblast growth factor 21 (FGF21) by -161.2 pg/mL (p=0.035), suggesting normalization of hepatokine secretion patterns associated with improved metabolic health.
What the research says
1 studyThe study tested the exact same diet as the claim and found that it lowered a specific hormone (FGF21) in people with diabetes and obesity, which matches what the claim says and suggests better health.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.